CIC
PRAH

Cornercap Investment Counsel’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cornercap Investment Counsel’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,373
Closed -$1.05M – 631
2021
Q2 		$1.05M Sell
6,373
-1,765
-22% -$295K 0.12% 330
2021
Q1 		$1.25M Buy
+8,138
New +$1.11M 0.14% 238
2020
Q4 		– Sell
-8,757
Closed -$888K – 648
2020
Q3 		$888K Sell
8,757
-12
-0.1% -$1.22K 0.13% 251
2020
Q2 		$853K Sell
8,769
-1,079
-11% -$100K 0.14% 271
2020
Q1 		$818K Buy
+9,848
New +$960K 0.16% 195
2017
Q2 		– Sell
-9,595
Closed -$626K – 398
2017
Q1 		$626K Sell
9,595
-2,765
-22% -$163K 0.11% 205
2016
Q4 		$681K Buy
12,360
+470
+4% +$25.8K 0.12% 182
2016
Q3 		$672K Sell
11,890
-65
-0.5% -$3.19K 0.12% 153
2016
Q2 		$499K Buy
11,955
+1,280
+12% +$59K 0.09% 257
2016
Q1 		$456K Buy
+10,675
New +$451K 0.09% 285

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Cornercap Investment Counsel's PRAH Position: Q3 2021 in Review

Cornercap Investment Counsel sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 6,373 shares — an estimated $1.05M sold.

Cornercap Investment Counsel first reported a position in PRAH in Q1 2016 and held it in 10 quarters. The position peaked at $1.25M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Cornercap Investment Counsel reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Cornercap Investment Counsel sold 6,373 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.05M.
  • Cornercap Investment Counsel first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 10 quarters.
  • Cornercap Investment Counsel's PRA Health Sciences, Inc. position peaked at $1.25M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Cornercap Investment Counsel's 13F filing for Q3 2021, filed 15 Nov 2021.